• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较第 6 版和第 7 版美国癌症联合委员会肿瘤-淋巴结-转移分期系统在食管癌切除患者中的应用。

Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.

机构信息

Department of Surgery, Chutung Veterans Hospital, Hsinchu county, and School of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

Ann Thorac Surg. 2010 Apr;89(4):1024-31. doi: 10.1016/j.athoracsur.2010.01.017.

DOI:10.1016/j.athoracsur.2010.01.017
PMID:20338302
Abstract

BACKGROUND

The 7th edition American Joint Committee on Cancer tumor-nodes-metastasis (AJCC TNM) staging system was published recently. We aim to evaluate its predictive ability and to compare the performance of the 6th and 7th editions of the AJCC TNM staging systems in esophageal cancer.

METHODS

A total of 392 esophageal squamous cell carcinoma patients receiving primary surgical resection between 1995 and 2006 were included. Patients were staged using the 6th and 7th edition staging systems. Survival analysis was performed with a Cox regression model. The homogeneity, discriminatory ability, and monotonicity of gradients of two staging systems were compared using linear trend chi2, likelihood ratio chi2 statistics, and Akaike information criterion calculation.

RESULTS

The overall five-year survival rate for the entire cohort was 27.1%. Female gender, "T," "N," and "M" classifications according to the 7th edition staging system definition were independent prognostic factors in multivariate analysis. But histology grade and cancer location had no significant influence on patient survival. The 7th edition staging system has the highest linear trend chi2 and likelihood ratio chi2 scores. Compared with the 6th edition, the 7th edition staging system also has a smaller Akaike information criterion value, which represented the optimum prognostic stratification.

CONCLUSIONS

The strength of the 7th edition AJCC TNM staging system is the new descriptors for "N" and "M" classifications. However, we did not find histologic grade and cancer location to be significant prognostic factors in our cohort. Overall, the 7th edition AJCC TNM staging system has better performance than the previous edition.

摘要

背景

第七版美国癌症联合委员会(AJCC)肿瘤-淋巴结-转移(TNM)分期系统最近发布。我们旨在评估其预测能力,并比较第六版和第七版 AJCC TNM 分期系统在食管癌中的表现。

方法

共纳入 1995 年至 2006 年间接受根治性手术的 392 例食管鳞状细胞癌患者。患者分期采用第六版和第七版分期系统。采用 Cox 回归模型进行生存分析。使用线性趋势 χ2、似然比 χ2 统计量和赤池信息量准则(Akaike information criterion,AIC)计算比较两种分期系统的同质性、区分能力和梯度单调性。

结果

全队列的总体五年生存率为 27.1%。女性性别、第七版分期系统定义的“T”、“N”和“M”分类是多因素分析中的独立预后因素。但组织学分级和肿瘤位置对患者生存无显著影响。第七版分期系统具有最高的线性趋势 χ2 和似然比 χ2 得分。与第六版相比,第七版分期系统的 AIC 值更小,代表了最佳的预后分层。

结论

第七版 AJCC TNM 分期系统的优势在于“N”和“M”分类的新描述符。然而,我们在本队列中并未发现组织学分级和肿瘤位置是显著的预后因素。总体而言,第七版 AJCC TNM 分期系统的性能优于上一版。

相似文献

1
Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.比较第 6 版和第 7 版美国癌症联合委员会肿瘤-淋巴结-转移分期系统在食管癌切除患者中的应用。
Ann Thorac Surg. 2010 Apr;89(4):1024-31. doi: 10.1016/j.athoracsur.2010.01.017.
2
Prognosis of esophageal squamous cell carcinoma patients with preoperative radiotherapy: Comparison of different cancer staging systems.术前放疗的食管鳞癌患者预后:不同癌症分期系统的比较。
Thorac Cancer. 2014 May;5(3):204-10. doi: 10.1111/1759-7714.12079. Epub 2014 Apr 22.
3
Comparison of 6th and 7th AJCC TNM staging classification for carcinoma of the stomach in China.中国胃癌第 6 版与第 7 版 AJCC TNM 分期比较。
Ann Surg Oncol. 2011 Jul;18(7):1869-76. doi: 10.1245/s10434-010-1542-x. Epub 2011 Jan 19.
4
Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.第六和第七版美国癌症联合委员会 TNM 分期系统对接受放化疗的食管癌患者的预后影响。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):946-52. doi: 10.1016/j.ijrobp.2010.12.045. Epub 2011 Feb 28.
5
[Preliminary experience of clinical applications of the 7th UICC-AJCC TNM staging system of esophageal carcinoma].[国际抗癌联盟(UICC)-美国癌症联合委员会(AJCC)第7版食管癌TNM分期系统的临床应用初步经验]
Zhonghua Zhong Liu Za Zhi. 2012 Jun;34(6):461-4. doi: 10. 3760/cma.j.issn.0253-3766.2012.06.013.
6
Proposed Modification of Nodal Staging as an Alternative to the Seventh Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Improves the Prognostic Prediction in the Resected Esophageal Squamous-Cell Carcinoma.提出的淋巴结分期修改方案作为美国癌症联合委员会肿瘤-淋巴结-转移分期系统第七版的替代方案,可以改善可切除食管鳞癌的预后预测。
J Thorac Oncol. 2015 Jul;10(7):1091-8. doi: 10.1097/JTO.0000000000000580.
7
Developing an appropriate staging system for esophageal carcinoma.开发一种适用于食管癌的分期系统。
J Am Coll Surg. 2005 Dec;201(6):884-90. doi: 10.1016/j.jamcollsurg.2005.07.002. Epub 2005 Oct 10.
8
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.上颌窦癌的治疗:1997年与1977年美国癌症联合委员会分期系统的比较
Cancer. 1999 Nov 1;86(9):1700-11.
9
Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer.比较新旧(第 6 版和第 7 版)TNM 分类在晚期胃癌中的分期。
Anticancer Res. 2011 Jun;31(6):2361-5.
10
Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.新辅助治疗后食管癌分期的细化:治疗反应的重要性。
Ann Surg Oncol. 2008 Oct;15(10):2894-902. doi: 10.1245/s10434-008-0084-y. Epub 2008 Jul 29.

引用本文的文献

1
Development and validation of the novel subclassification of pN3 for patients with esophageal cancer.食管癌患者pN3新亚分类的开发与验证
Front Oncol. 2023 May 2;13:1113711. doi: 10.3389/fonc.2023.1113711. eCollection 2023.
2
Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy.接受根治性同步放化疗的食管鳞状细胞癌患者中转移性淋巴结总体积的预后价值。
Front Oncol. 2022 Nov 10;12:996293. doi: 10.3389/fonc.2022.996293. eCollection 2022.
3
The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma.
改良的肿瘤-淋巴结-转移分期系统结合淋巴管侵犯在食管鳞状细胞癌患者中的分期表现。
Front Oncol. 2022 Oct 13;12:1018827. doi: 10.3389/fonc.2022.1018827. eCollection 2022.
4
The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study.局部晚期食管鳞癌患者术前新辅助放化疗效果受辐射剂量影响:一项倾向评分匹配的回顾性研究。
J Immunol Res. 2022 Oct 15;2022:7581799. doi: 10.1155/2022/7581799. eCollection 2022.
5
SDF-1α predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy.基质细胞衍生因子-1α 预测接受根治性同步放化疗的局部晚期食管鳞癌患者预后不良。
Biomed J. 2022 Jun;45(3):522-532. doi: 10.1016/j.bj.2021.05.004. Epub 2021 May 19.
6
Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer.肿瘤比例转移分期系统与第八版美国癌症联合委员会(AJCC)胃癌TNM分期系统的比较
Front Oncol. 2021 Jul 8;11:595421. doi: 10.3389/fonc.2021.595421. eCollection 2021.
7
LYMPHOPARIETAL INDEX IN ESOPHAGEAL CANCER IS STRONGER THAN TNM STAGING IN LONG-TERM SURVIVAL PROGNOSIS IN A LATIN-AMERICAN COUNTRY.在拉丁美洲国家,食管癌的淋巴旁指数比 TNM 分期在长期生存预后方面更强。
Arq Bras Cir Dig. 2021 Jan 15;33(3):e1547. doi: 10.1590/0102-672020200003e1547. eCollection 2021.
8
miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer.miR-221-3p和miR-15b-5p通过靶向肝癌中的Axin2促进细胞增殖和侵袭。
Oncol Lett. 2019 Dec;18(6):6491-6500. doi: 10.3892/ol.2019.11056. Epub 2019 Nov 5.
9
Associations Between Apparent Diffusion Coefficient Value With Pathological Type, Histologic Grade, and Presence of Lymph Node Metastases of Esophageal Carcinoma.表观扩散系数值与食管癌病理类型、组织学分级和淋巴结转移存在的相关性。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819892254. doi: 10.1177/1533033819892254.
10
Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma.三维适形放疗或调强放疗同步化疗治疗胸段食管鳞状细胞癌患者
Cancers (Basel). 2019 Oct 10;11(10):1529. doi: 10.3390/cancers11101529.